Pablo Cagnoni, President, Global Head of R&D at Incyte, holds 183.20K shares in Incyte (Ticker: INCY), holds 0.00 shares in Onyx Pharma (Ticker: ONXX), holds 66.08K shares in Rubius Therapeutics (Ticker: RUBY). Most recently, Pablo Cagnoni Sold ― shares of Incyte on Aug 20, 2026 for an estimated value of $1.36M.
What is the percentage of profitable transactions made by Pablo Cagnoni?
The percentage of profitable transactions made by Pablo Cagnoni is 25%.
What is the average return per transaction made by Pablo Cagnoni?
The average return per transaction made by Pablo Cagnoni is 41.00%.
What stocks does Pablo Cagnoni hold?
Pablo Cagnoni holds: INCY, ONXX, CRSP, RUBY, FUSN stocks.
What was Pablo Cagnoni’s latest transaction?
Pablo Cagnoni latest transaction was an Informative Sell of $1.36M.
What was Pablo Cagnoni's most profitable transaction?
Pablo Cagnoni’s most profitable transaction was an Informative Buy of RUBY stock on April 15, 2020. The return on the trade was 436.80%.
What is Pablo Cagnoni's role in Incyte?
Pablo Cagnoni's role in Incyte is President, Global Head of R&D.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.